Donor-derived cell-free DNA as a new biomarker for acute rejection in heart transplant recipients: results from the freedna car study

Back

ESC Professional Premium Access

Donor-derived cell-free DNA as a new biomarker for acute rejection in heart transplant recipients: results from the freedna car study

Session: Heart transplantation

Topic: Heart Transplantation

Speaker: Doctor M. Jimenez-Blanco Bravo (Madrid, ES)

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speaker

Doctor Marta Jimenez-Blanco Bravo

Ramon and Cajal University Hospital, Madrid (Spain)

0 follower

6 more presentations in this session

Reduction of cardiac allograft vasculopathy by PCI: Quantification and correlation with outcome after heart transplantation

Speaker: Doctor M. Orban (Munich, DE)

Cardiac rejection diagnosis using serum mRNA encoding proteins related to fibrotic process

Speaker: Miss M. Delgado Arija (Valencia, ES)

Necropsy findings in heart transplant recipients with and without primary graft dysfunction: a retrospective study

Speaker: Doctor D. Belfort (Sao Paulo, BR)

Pretransplant erythroferrone levels are predictive of 1-year all-cause mortality or acute rejection after heart transplantation

Speaker: Doctor B. Pitta Gros (Lausanne, CH)

Donor-derived cell-free DNA kinetics in the first year post-transplant in patients without acute cellular rejection

Speaker: Doctor M. Jimenez-Blanco Bravo (Madrid, ES)

Access the full session

Heart transplantation

Speakers: Doctor M. Jimenez-Blanco Bravo, Doctor M. Orban, Miss M. Delgado Arija, Doctor D. Belfort, Doctor B. Pitta Gros...

Access

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources